| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.7 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |